Abstract
BACKGROUND: Various Pulpotomy medicaments like Formocresol, Glutaraldehyde, Ferric sulfate, Calcium-hydroxide, MTA, Bone Morphogenic proteins, Collagen, Bioactive glass and Laser have been advocated for use in treatment of pulpally involved primary teeth but the Formocresol pulpotomy technique is the universally taught & preferred pulp therapy for primary teeth. Despite years of apparent successful use as a pulpotomy agent, Formocresol has come under the attack for research & documentation in the literature which have shown it to be toxic, mutagenic & carcinogenic. This debate over the use of Formocresol solution & other formaldehyde containing preparations in children's dentistry continues. The determination of the actual effective dose and concentration for clinical application for pulpotomy in primary teeth is an important area of further research & a thorough clinical, radiographic & histologic investigation in human subjects is very much needed with various dilutions of Formocresol. AIM: To inquire about the use of Formocresol for primary as well as permanent tooth pulpotomy and to know the awareness about the diluted formulations of Formocresol among Indian Pediatric dentists. MATERIALS & METHODS: The questionnaire to know the use of Formocresol by the Pedodontists across India was e-mailed to 165 pediatric dentists out of whom only 120 replied/responded. Thirty eight respondents were academicians and faculty in the field of pediatric dentistry and the remaining 82 were the post graduates students. RESULTS: The results showed that 95% of the respondents use Formocresol for routine pulpotomy procedure in primary teeth. Of those, 42% use full strength Formocresol, 40% use dilute Formocresol & 18% do not know what concentration they are using. CONCLUSION: The study concludes that Formocresol remains the most popular medicament in use for primary tooth pulpotomy followed by calcium hydroxide and MTA, glutaraldehyde and ferric sulphate in the field of Pediatric Dentistry across the country. There is a need for the diluted Formocresol to be made commercially available.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Evolution of Medical and Dental sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
